The effectiveness and safety of subcutaneous immunotherapy for inhalable allergens in patients with respiratory allergies after one year of treatment. Revista Alergia México, [S. l.], v. 67, n. 4, p. 309–315, 2021. DOI: 10.29262/ram.v67i4.758. Disponível em: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/758. Acesso em: 24 sep. 2026.